APH vs HCAT · P/E 40, rev $23.09B vs rev $306.6M
Amphenol Corporation (APH) versus Health Catalyst Inc (HCAT) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Health Catalyst Inc (HCAT) is a health information services company listed on NASDAQ.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported HCAT revenue for 2024-12-31 was $306.6M. Net income was -$69.5M. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. HCAT currently screens at market cap $130.8M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. HCAT currently screens at market cap $130.8M.
Not investment advice. Open the APH and HCAT stock pages for the full models.
Not investment advice.